VETOQUINOL Corporate brochure 2010 (year 2009)

18 MARKETING MORE THAN JUST PACKAGING, ADDING VALUE Vétoquinol products target three strong, differentiated areas of expertise: anti-infectives, pain- inflammation and cardiology- nephrology. The Group offers product ranges that have become market leaders in the animal health sector and have enabled it to become one of the European leader in anti- infectives for companion animals. Vétoquinol has made clear strategic choices, aimed at strengthening its expertise as well as its market positions. By staying intensely focused on three main therapeutic areas, the Group is in a position to optimise its investments in R & D, production and marketing. LEADER IN THE ANTI-INFECTIVES MARKET As a creator of innovative antibiotics, Vétoquinol is one of the European market leader in anti-infectives for companion animals and ranks third in anti-infective injectables for livestock. The Group has several major brands. Marbocyl ® , its best- selling antibiotic range, is ranked in the top five anti-infectives in the European market. Developed for the treatment of otitis in dogs and cats, Aurizon ® (the only fluoroquinolone that can be used locally) and Oridermyl ® are also among the leading products in this market. More recent products like Clavaseptin ® and Enisyl ® have also further reinforced the Group’s position.